GranBio Is The Operator Of The First Commercial-Scale Cellulosic Ethanol Plant In The Southern Hemisphere And Is Located In Alagoas
The Brazilian industrial biotechnology company, GranBio, announced on Friday the hiring of several biorefinery facilities in the U.S., as well as a research and development (R&D) center and other assets. More specifically, GranBio has completed the acquisition of American Process Inc and several affiliated companies, such as AVAPCO LLC and API Intellectual Properties Holdings, for an undisclosed amount.
The transaction covers the Alpena Biorefinery in Michigan, the Thomaston Biorefinery, and the R&D center in Georgia, as well as the operations, research, and business development teams. Additionally, GranBio acquired the intellectual property (IP) portfolio in the fields of biorefinery, biofuels, biochemicals, and nanocellulose, with over 200 granted and pending patents.
-
Government unlocks R$ 554 million for a highway that has been requested for decades and accelerates the duplication of BR.
-
Without bricks, without cement, and without endless construction: the cardboard house that is assembled in modules and can be moved.
-
Billions of barrels on the equatorial margin could lead Amapá to double its oil production in Brazil — the state aims to enter the route of companies in the Campos Basin, attract investments, and boost jobs and businesses in the oil and gas sector.
-
Without bricks, without cement, and without endless construction: the cardboard house that is assembled in modules and can be moved.
GranBio is the operator of the first commercial-scale cellulosic ethanol plant in the Southern Hemisphere, known as Bioflex 1. The plant is located in Alagoas, Brazil, and converts biomass from sugarcane waste, straw, and bagasse.

Seja o primeiro a reagir!